giiant pharma Revenue and Competitors
Estimated Revenue & Valuation
- giiant pharma's estimated annual revenue is currently $387.5k per year.
- giiant pharma's estimated revenue per employee is $77,500
Employee Data
- giiant pharma has 5 Employees.
- giiant pharma grew their employee count by -17% last year.
giiant pharma's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
giiant pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $25.9M | 181 | 3% | $150.5M | N/A |
#2 | $28.4M | 183 | -56% | N/A | N/A |
#3 | $4.3M | 28 | 8% | N/A | N/A |
#4 | $55.6M | 359 | 1% | N/A | N/A |
#5 | $11M | 71 | 20% | N/A | N/A |
#6 | $22.2M | 143 | -22% | N/A | N/A |
#7 | $4.2M | 27 | 13% | N/A | N/A |
#8 | $2M | 13 | 0% | N/A | N/A |
#9 | $295.7M | 1908 | 5% | N/A | N/A |
#10 | $2.8M | 18 | 6% | N/A | N/A |
What Is giiant pharma?
Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.
keywords:N/AN/A
Total Funding
5
Number of Employees
$387.5k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 5 | -67% | N/A |
#2 | $0.4M | 5 | -55% | N/A |
#3 | $0.7M | 5 | 0% | N/A |
#4 | $0.5M | 5 | 0% | N/A |
#5 | $0.6M | 5 | -29% | N/A |